In contrast to the genes mentioned above, Myoferlin as shown by various studies is indeed relevant concerning cancerous disease: it is generally up-regulated in tumors, e.g., in esophagal, renal, and glioblastoma with a strong correlation to survival of patients with glioma and pancreatic adenocarcinoma [11]. The gene discussed is MYOF; the disease is pancreatic adenocarcinoma.